Bariatrik Cerrahi Olgularında Preoperatif Değerlendirme Sırasında Tespit Edilen Hastalıkların Prevalansı

Year 2020, Volume: 10 Issue: 4, 650 - 654, 15.12.2020

Feyzi Gökosmanoğlu , Kerim Güzel , Gülşah Bayçelebi

https://doi.org/10.31832/smj.791837

Abstract

Giriş: Obezite prevalansı dünya çapında artmaktadır. Bu durum önemli bir sağlık sorunu haline geldi. Morbid obezitede başarılı tedavi yöntemlerinden biride bariatrik cerrahidir. Obeziteye eşlik eden hastalıkların tesbit edilmesi, preoperatif mortalite riskini ve postoperatif başarıyı öngörmemizi sağlayacaktır.
Gereç ve Yöntemler: Araştırmamız Ekim 2016-Ağustos 2020 yılları arasında hastanemiz Metabolik ve Bariatrik Cerrahi kliniğimizde morbid obezite nedeni ile bariatrik cerrahi yapılan toplam 742 olgu üzerinde yürütüldü.

Bulgular: Dosyaları incelenen 742 hastanın kayıtları değerlendirildi. Hastaların 474 kadın, 268 erkek, yaş ortalaması 50.8 ± 8.9 yıl, ortalama vücut kitle indeksi (VKİ) 48.9 ± 5.0 kg/m2 idi. Obezite prevalansındaki artış ile tip-2 diyabet, hipertansiyon, metabolik sendrom ve diğer hastalıklarda ciddi artışlar tesbit edildi. Tiroid ve adrenal bez hastalıklarında artış yada tesbit edilme sıklığı göze çarpmaktadır.

Sonuç: Obezite prevalansındaki artış ile birlikte obeziteye eşlik eden hastalıklarda da artış saptanmaktadır. Obezite olguları preoperatif dönemde değerlendirilmeleri sırasında eşlik eden hastalıkların saptanması, cerrahi öncesi tedavisi, cerrahiye bağlı mortalite ve morbiditeyi azaltır, cerrahinin başarısını artırır.

Objective: The prevalence of obesity is increasing worldwide. This has become an important health problem. One of the successful treatment methods in morbid obesity is the bariatric surgery. Detecting the diseases that accompany obesity will enable us to predict the risk of preoperative mortality and postoperative success.

Materials and Methods: The present study was conducted between October 2016 and August 2020 on a total of 742 cases that under went bariatric surgery because of morbid obesity in our hospital Metabolic and Bariatric Surgery Clinic.

Results: The records of a total of 742 patients whose medical files were examined were evaluated in the study. The mean age of 474 women, 268 men was 50.8 ± 8.9 years, the mean Body Mass Index (BMI) was 48.9 ± 5.0 kg/m2. Significant increases were detected with the increase in obesity prevalence and Type-2 Diabetes, Hypertension, Metabolic Syndrome and other diseases. The frequency of increase or detection of thyroid and adrenal glands diseases was also noticeable in this respect.

Conclusion: An increase was detected in the diseases that accompany obesity with the increase in obesity prevalence. Obesity decreases the detection of comorbidities during the evaluation of cases in preoperative period, pre-surgical treatment, and reduces mortality and morbidity because of surgery, and increases the success of surgery.

Keywords

Bariatrik cerrahi, preoperatif değerlendirme, obezite

References

• 1) Aguilera C, Labbé T, Busquets J, Venegas P, Neira C, Valenzuela Á. Obesity: risk factor or primary disease?. Rev Med Chil 2019;147(4):470-474.
• 2) Engin A. The Definition and Prevalence of Obesity and Metabolic Syndrome. Adv Exp Med Biol 2017;960:1-17.
• 3) Lee CJ, Clark JM, Asamoah V, Schweitzer M, Magnuson T, Lazo M. Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese. Surg Obes Relat Dis 2015;11(1):142-146.
• 4) Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122(3):248-256.
• 5) Thomas H, Agrawal S. Systematic review of obesity surgery mortality risk score preoperative risk stratification in bariatric surgery. Obes Surg 2012;22(7):1135-40.
• 6) Ferrada P, Anand RJ, Malhotra A, Aboutanos M. Obesity Does Not Increase Mortality after Emergency Surgery. Journal of Obesity 2014:1–3.
• 7) Bell T, Stokes S, Jenkins PC, Hatcher L, Fecher AM. Prevalence of cardiovascular and respiratory complications following trauma in patients with obesity. Heart Lung 2017;46(5):347-350.
• 8) Ortiz VE, Kwo J. Obesity: physiologic changes and implications for preoperative management. BMC Anesthesiol 2015;4;15:97.
• 9) George A. Bray, Medical Consequences of Obesity, The Journal of Clinical Endocrinology & Metabolism 2004;2583–2589.
• 10) Mc Donald A, Bradshaw RA, Fontes F. Prevalence of obesity in panama: some risk factors and associated diseases. BMC Public Health 2015;15:1075.
• 11) Cinza Sanjurjo S, Prieto Díaz MÁ, Llisterri Caro JL. Prevalencia de obesidad y comorbilidad cardiovascular asociada en los pacientes incluidos en el estudio IBERICAN (Identificación de la poBlación Española de RIesgo CArdiovascular y reNal) [Prevalence of obesity and cardiovascular comorbidity associated in patients included in the IBERICAN study]. Semergen 2019;45(5):311-322.
• 12) Balkan F. Metabolik Sendrom. Ankara Medical Journal 2013;13:2.
• 13) Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol 2013;62(7):569-576.
• 14) Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014;383(9918):736-747.
• 15) Grewal G, Joshi GP. Obesity and Obstructive Sleep Apnea in the Ambulatory Patient. Anesthesiol Clin 2019;37(2):215-224
• 16) Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin North Am 2014;43(1):161-173.
• 17) Khatua B, El-Kurdi B, Singh VP. Obesity and pancreatitis. Curr Opin Gastroenterol 2017;33(5):374-382.
• 18) Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol 2014;20(28):9330-9337.
• 19) Verma A, Jayaraman M, Kumar HK, Modi KD. Saudi Med J 2008;29(8):1135-8.
• 20) Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: An intriguing link. Indian J Endocrinol Metab 2016;20(4):554-557.
• 21) Ríos-Prego M, Anibarro L, Sánchez-Sobrino P. Relationship between thyroid dysfunction and body weight: a not so evident paradigm. Int J Gen Med 2019;12:299-304.
• 22) Sousa PA, Vaisman M, Carneiro JR. Prevalence of goiter and thyroid nodular disease in patients with class III obesity. Arq Bras Endocrinol Metabol 2013;57(2):120-125.
• 23) Gokosmanoglu F, Aksoy E, Onmez A, Ergenç H, Topkaya S. Thyroid Homeostasis After Bariatric Surgery in Obese Cases. Obes Surg 2020;30(1):274-278.
• 24) Ayloo S, Thompson K, Choudhury N, Sheriffdeen R. Correlation between the Beck Depression Inventory and bariatric surgical procedures. Surg Obes Relat Dis 2015;11(3):637-642.
• 25) Alabi F, Guilbert L, Villalobos G. Depression Before and After Bariatric Surgery in Low-Income Patients: the Utility of the Beck Depression Inventory. Obes Surg 2018;28(11):3492-3498.
• 26) Petri E, Bacci O, Barbuti M. Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-Mix study. Bipolar Disord 2017;19(6):458-464.
• 27) Reincke M, Beuschlein F, Bornstein S. The Adrenal Gland: Central Relay in Health and Disease. Exp Clin Endocrinol Diabetes 2019;127(2-03):81-83.
• 28) Unger N. Inzidentalome der Nebennieren : Diagnostisches und therapeutisches Konzept aus endokrinologischer Sicht [Adrenal incidentaloma : Diagnostic and therapeutic concept from an endocrinological perspective] [published correction appears in Chirurg 2019 Feb 8;:]. Chirurg 2019;90(1):3-8.
• 29) Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev 2013;22(8):1395-40.
• 30) Kushchayeva YS, Kushchayev SV, Startzell M. Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes. J Clin Endocrinol Metab 2019;104(6):2216-2228.